Australia | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Australia totalled $ 2.66 billion in 2023. Sales of commodity group 30 from Australia went up by 5.14% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 130 million (cumulative exports of commodity group 30 from Australia amounted $2.53 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.721% of total exports from Australia (cumulative merchandise exports from Australia totalled $ 369 billion in 2023). The share of commodity group 30 in total exports from Australia increased by 0.103 p.p. compared to 2022 (it was 0.617% in 2022 and cumulative exports from Australia were equal to $ 410 billion).
Where does Australia export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Australia in 2023:
- USA with a share of 40% (1.06 billion US$)
- New Zealand with a share of 15.4% (411 million US$)
- China with a share of 13.9% (372 million US$)
- Germany with a share of 3.13% (83 million US$)
- Japan with a share of 2.73% (72 million US$)
- Switzerland with a share of 2.48% (66 million US$)
- Hong Kong with a share of 2.33% (62 million US$)
- Korea with a share of 1.84% (49 million US$)
- Belgium with a share of 1.66% (44 million US$)
- Singapore with a share of 1.4% (37 million US$)
Exports structure of 30 - Pharmaceutical products - from Australia in 2023 represented by the following main commodity groups:
- 50% (1.34 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 42% (1.12 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 3.39% (90 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.48% (39 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.26% (33 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 1.01% (26 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
The value of imports of commodity group 30 "Pharmaceutical products" to Australia totalled $ 11.3 billion in 2023. Sales of commodity group 30 to Australia decreased by 15.2% in value terms compared to 2022. imports of commodity group 30 "Pharmaceutical products" decreased by $ 2.04 billion (the value of imports of commodity group 30 to Australia was equal to $13.3 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.94% of total import flow to Australia (in 2023, total imports to Australia amounted to $ 287 billion). The share of commodity group 30 in total imports to Australia decreased by 0.388 p.p. compared to 2022 (it was 4.33% in 2022 and cumulative imports to Australia were equal to $ 309 billion).
Imports of commodity group 30 reached 99% of total imports of group 30 "Pharmaceutical products" to Australia in 2023 (imports of commodity group 30 to Australia totalled $11.3 billion in 2023). The share of purchases of commodity group 30 in imports of commodity group 30 to Australia went down by 0 p.p. compared to 2022 (it was 100% in 2022, and imports of commodity group 30 to Australia accounted for $13.3 billion).
Where does Australia import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Australia in 2023:
- USA with a share of 21% (2.47 billion US$)
- Germany with a share of 13.6% (1.55 billion US$)
- Belgium with a share of 8.31% (944 million US$)
- Ireland with a share of 7.11% (807 million US$)
- Switzerland with a share of 7.1% (806 million US$)
- France with a share of 5.05% (574 million US$)
- India with a share of 4.66% (530 million US$)
- Italy with a share of 4.58% (520 million US$)
- United Kingdom with a share of 4.19% (476 million US$)
- Denmark with a share of 3.54% (401 million US$)
Imports structure of 30 - Pharmaceutical products - to Australia in 2023 represented by the following main commodity groups:
- 54% (6.18 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 40% (4.55 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.72% (309 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.8% (205 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.427% (48 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.394% (44 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
